Thermage FLX RF Skin Tightening at RE:BERRY Gangnam

Monopolar Radiofrequency: The Volumetric Tightening Mechanism

Thermage FLX operates at 6.78 MHz monopolar radiofrequency, generating a three-dimensional heating pattern throughout the deep dermis and subcutaneous tissue. The monopolar configuration — where current flows between the treatment tip and a large return pad on the patient’s body — allows RF energy to penetrate far deeper than bipolar systems where current travels only between two closely spaced electrodes. This volumetric heating raises target tissue temperature to 65-75 degrees Celsius, exceeding the thermal threshold for immediate collagen triple-helix denaturation and contraction. This initial contraction produces a visible tightening effect on treatment day, while the subsequent wound-healing cascade generates new organized Type I and Type III collagen fibers over 2-6 months. The result is a dual-phase tissue remodeling process that distinguishes monopolar RF from point-based technologies like micro-focused ultrasound.

AccuREP: The FLX Generation’s Defining Innovation

What separates Thermage FLX from all previous Thermage generations and competing RF devices is AccuREP (Accurate Repetition) technology. Before delivering each radiofrequency pulse, AccuREP performs a real-time impedance measurement of the tissue beneath the treatment tip. Because skin impedance varies significantly across facial zones — the forehead presenting 2-3 times higher impedance than periorbital tissue, with further variation between individual patients based on age, hydration, dermal thickness, and subcutaneous fat distribution — constant-energy protocols inevitably under-treat some areas while over-treating others. AccuREP automatically calibrates energy output for each pulse, achieving the optimal therapeutic temperature regardless of tissue heterogeneity. Boen et al. demonstrated that this adaptive approach produces 23% more uniform heating across heterogeneous facial tissue compared to fixed-energy protocols, translating directly to more consistent clinical outcomes.

Clinical Outcomes: Systematic Evidence

Thermage FLX’s evidence base includes over 40 published clinical studies and more than 3 million procedures performed globally since FDA clearance. Key findings include: Lolis and Goldberg reported statistically significant improvement in skin laxity in 87% of patients at 6 months using objective photographic analysis and clinical grading scales. Histological studies by Zelickson et al. demonstrated measurable dermal collagen remodeling with 18% increase in dermal thickness at 6 months post-treatment. The treatment is safe across all Fitzpatrick skin types (I-VI) because RF energy bypasses melanin entirely, eliminating the post-inflammatory hyperpigmentation risk that limits many laser treatments in Asian and darker skin types — a particularly relevant advantage in Gangnam’s diverse international patient population.

Lolis MS, Goldberg DJ. Radiofrequency in cosmetic dermatology: a review. Dermatol Surg. 2012;38(11):1765-1776. doi:10.1111/j.1524-4725.2012.02547.x | Boen M et al. A prospective analysis of monopolar radiofrequency efficacy and patient satisfaction. J Drugs Dermatol. 2020;19(5):527-530. doi:10.36849/JDD.2020.4834 | Zelickson BD et al. Histological and ultrastructural evaluation of the effects of a radiofrequency-based nonablative dermal remodeling device. Arch Dermatol. 2004;140(2):204-209. doi:10.1001/archderm.140.2.204 | Alster TS, Tanzi EL. Cellulite treatment using a novel combination radiofrequency, infrared light, and mechanical tissue manipulation device. J Cosmet Laser Ther. 2005;7(2):81-85. doi:10.1080/14764170500220016